Company: SATLW
Filing Date: 2025-03-26
Form Type: 10-K
Source: 0001628280-25-014951
Chunk: 37

Company: Satellogic Inc.
Filing Date: 2025-03-26
Form: 10-K
Item: Item 8
Chunk 37
---
)5,995 374 1,082 50,595 At December 31, 2024$8,012 $471 $1,501 $79,070 (1)Recognized in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2024 and 2023, respectively.There were no transfers between Level 1 and Level 2 during the years ended December 31, 2024 or 2023.

101

Table of ContentsSATELLOGIC INC. Notes to Consolidated Financial Statements (in thousands of U.S. dollars, except share and per share information, unless otherwise stated) 

16. Related Parties

See description of transactions with CF&Co. and Liberty Investment as part of the Merger Transaction described in Note 4.(Reverse Recapitalization). We made purchases totaling $1.3 million from our equity method investee, OS, in the year ended December 31, 2024 and there was $0.0 million owed to OS and included in accounts payable at December 31, 2024. We made purchases totaling $1.8 million from our equity method investee, OS, in the year ended December 31, 2023 and there was $0.3 million owed to OS and included in accounts payable at December 31, 2023. See Note 20 (Equity Method Investment).On December 20, 2024, we entered into a Sales Agreement with CF&Co.. Under the Sales Agreement, CF&Co is acting as a  sales agent to the Company, pursuant to which the Company may offer and sell, from time to time, through the Sales Agent, its Class A common stock, having an aggregate offering amount of up to $50,000,000. The Sales Agreement was amended and restated on February 12, 2025; however, the Sales Agreement, as amended and restated, did not increase the amount of Class A common stock that may be offered and sold by the Company under the original Sales Agreement entered into on December 20, 2024. Pursuant to the Amended Sales Agreement, when designated as sales agent for a particular sale, CF&Co. is to be paid a commission, in cash, at a fixed rate of 3.0% of the gross sales price per share sold under the Amended Sales Agreement. CF&Co. is also entitled to reimbursement for certain specified expenses